vRad (Virtual Radiologic) announced that it has implemented its first breast imaging Live Video Diagnostics solution site at the Center for Women’s Imaging at Medical Center Hospital (MCH) using Cisco technology.

To help readers find the specific technology they are looking for out of the 700 vendors on the vast expo floor at the Radiological Society of North America (RSNA) meeting Nov. 27 - Dec. 2, ITN has created the RSNA FastPass microsite (www.rsnafastpass.com). Every day leading up to RSNA, during the event and in the weeks following RSNA, ITN staff will be adding new products vendors are featuring. Visitors to the FastPass site can conduct searches by modality or technology type, and each section lists vendors in alphabetical order.

A supplemental “boost” of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with ductal carcinoma in situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to new research. Researchers concluded that use of a radiation boost should be considered in DCIS patients who have life expectancies of 10 or more years following breast-conserving surgery and WBRT.

Agfa Healthcare recently announced that its offerings at the 2016 annual meeting of the Radiological Society of North America (RSNA) will center on the theme of “Care You Can See" across the company's entire product portfolio.

Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago, including the latest advances in ultrasound.

October 10, 2016 — Novarad’s most recent software development has enabled the company to achieve a bi-directional integration between its picture archiving and communication system (PACS) and Epic’s radiology information system (RIS).

People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet. The phase 3 randomized trial found that whole brain radiotherapy had no beneficial effect on length or quality of survival over treatment with steroids and other supportive care.

American Society for Radiation Oncology 2017 Annual Meeting

ASTRO Immunotherapy Workshop

Subscribe Now